{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:48:37Z","timestamp":1789159717796,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejps.2023.106653","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:36:54Z","timestamp":1700800614000},"page":"106653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier"],"prefix":"10.1016","volume":"194","author":[{"given":"Yumeng","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuowei","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6065","authenticated-orcid":false,"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106653_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejps.2023.106653_bib0002","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1345\/aph.1A021","article-title":"An unusual presentation of sertraline and trazodone overdose","volume":"35","author":"Adson","year":"2001","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106653_bib0003","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1158\/0008-5472.CAN-03-4062","article-title":"Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions","volume":"64","author":"Breedveld","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2023.106653_bib0004","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1177\/106002809402801124","article-title":"Sertraline overdose","volume":"28","author":"Brown","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106653_bib0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/cns.13989","article-title":"Multiple drug transporters contribute to the brain transfer of levofloxacin","volume":"29","author":"Cen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejps.2023.106653_bib0006","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1177\/0271678X20985946","article-title":"Understanding the brain uptake and permeability of small molecules through the BBB: a technical overview","volume":"41","author":"Chowdhury","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2023.106653_bib29","series-title":"The Blood\u2013Brain Barrier","volume":"7","author":"Daneman","year":"2015"},{"key":"10.1016\/j.ejps.2023.106653_bib0007","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neo.2018.05.001","article-title":"Improved brain penetration and antitumor efficacy of temozolomide by inhibition of ABCB1 and ABCG2","volume":"20","author":"de Gooijer","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejps.2023.106653_bib0008","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jphp.13100","article-title":"In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein","volume":"71","author":"Feng","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106653_bib0009","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0006-3002(57)90529-2","article-title":"Graphical determination of the dissociation constants for two-substrate enzyme systems","volume":"25","author":"Florini","year":"1957","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2023.106653_bib0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2011.12.024","article-title":"A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers","volume":"59","author":"Frelinger","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2023.106653_bib0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FTD.0000000000000101","article-title":"Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline","volume":"37","author":"Gjestad","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2023.106653_bib0012","first-page":"930","article-title":"Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors","volume":"11","author":"Grimsley","year":"1992","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejps.2023.106653_bib0013","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.euroneuro.2013.01.003","article-title":"Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment","volume":"23","author":"Karlsson","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejps.2023.106653_bib0014","first-page":"853","article-title":"Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms","volume":"25","author":"Ko","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106653_bib0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","article-title":"Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities","volume":"32","author":"Li","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106653_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-13-7647-4_5","article-title":"Transporter-Mediated Drug-Drug Interactions and Their Significance","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejps.2023.106653_bib0017","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2023.106653_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bcpt.12938","article-title":"Effect of polymorphisms on the pharmacokinetics, pharmacodynamics and safety of sertraline in healthy volunteers","volume":"122","author":"Saiz-Rodr\u00edguez","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2023.106653_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejps.2023.106653_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejps.2023.106653_bib0022","doi-asserted-by":"crossref","first-page":"H484","DOI":"10.1152\/ajpheart.1984.247.3.H484","article-title":"An in situ brain perfusion technique to study cerebrovascular transport in the rat","volume":"247","author":"Takasato","year":"1984","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"key":"10.1016\/j.ejps.2023.106653_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/joim.13148","article-title":"Optimal management of severe symptomatic gastroesophageal reflux disease","volume":"289","author":"Talley","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejps.2023.106653_bib0024","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40261-016-0390-2","article-title":"Pharmacokinetics, pharmacodynamics and safety of multiple-infusion ilaprazole in healthy Chinese subjects","volume":"36","author":"Wang","year":"2016","journal-title":"Clin. Drug. Investig."},{"key":"10.1016\/j.ejps.2023.106653_bib0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2018.12.014","article-title":"P-glycoprotein (MDR1\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice","volume":"556","author":"Wang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106653_bib0026","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2174\/1567201818666210708122326","article-title":"Organic cation transporters are involved in fluoxetine transport across the blood-brain barrier in vivo and in vitro","volume":"19","author":"Wang","year":"2022","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.ejps.2023.106653_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.965432","article-title":"Unprescribed and unnoticed: retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs","volume":"13","author":"Woro\u0144","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106653_bib0028","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11096-016-0259-8","article-title":"Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients","volume":"38","author":"Yuce-Artun","year":"2016","journal-title":"Int. J. Clin. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:09:53Z","timestamp":1760530193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S0928098723002828"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106653","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106653"}}